Global Acne market to grow at a CAGR of 4.07 percent by 2018
- Written by Debora White
The analysts forecast that the Global Acne market to grow at a CAGR of 4.07 percent over the period 2013-2018. The Global Acne market can be divided into seven segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report covers the present scenario and the growth prospects of the Global Acne market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.
The report Global Acne Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Acne market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Actavis
• Allergen
• Galderma
• Stiefel Laboratories
• Valeant Pharmaceuticals International
Other Prominent Vendors
• Andro Science
• Bayer
• Cipher Pharmaceuticals
• Cosmo Pharmaceuticals
• Elorac
• Foamix Pharmaceuticals
• Helix BioMedix
• Hygeia Therapeutics
• IMTM
• J&J
• Mylan Pharmaceuticals
• NanoBio
• NovaLead Pharma
• F. Hoffmann-La Roche
Companies Mentioned
Actavis , Allergen , Galderma , Stiefel Laboratories , Valeant Pharmaceuticals International , Andro Science , Bayer , Cipher Pharmaceuticals , Cosmo Pharmaceuticals , Elorac , Foamix Pharmaceuticals , Helix BioMedix , Hygeia Therapeutics , IMTM , J&J ,Mylan Pharmaceuticals , NanoBio , NovaLead Pharma , F. Hoffmann-La Roche
To access full report with TOC, please visit http://www.reportstack.com/product/183723/global-acne-market-2014-2018.html
Contact:
Debora White
debora@reportstack.com
Reportstack Market Research

